Page 31 - Proceeding of Plenary Abstract of Parallel Symposim
P. 31

terkait aspek pemilihan tipe sel punca, dosis sel punca yang tepat, serta rute pemberiannya.

           Keywords: stem cell, chronic kidney disease, end stage renal disease, children

           Daftar pustaka

           1.   Becherucci F, Roperto RM, Materassi M, Romagnani P. Chronic kidney disease in children.
               Clin Kidney J. 2016;9:583–91.
           2.   Hogg RJ, Furth S, Lemley K V., Portman R, Schwartz GJ, Coresh J, dkk. National Kid-
               ney Foundation’s Kidney Disease Outcomes Quality Initiative clinical practice guidelines for
               chronic kidney disease in children and adolescents: evaluation, classification, and stratifica-
               tion. Pediatrics. 2003;111:1416–21.
           3.   McDonald SP, Craig JC. Long-term survival of children with end-stage renal disease. N Engl
               J Med. 2004;350:2654–62.
           4.   Marcheque J, Bussolati B, Csete M, Perin L. Concise reviews: stem cells and kidney regener-
               ation: an update. Stem Cells Transl Med. 2019;8:82–92.
           5.   Horwitz E, Andreef M, Frassoni F. Mesenchymal stromal cells. Curr Opin Hematol.
               2006;13:419–25.
           6.   Biehl JK, Russell B. Introduction to stem cell therapy. J Cardiovasc Nurs. 2009;24:98–103.
           7.   Andrzejewska A, Lukomska B, Janowski M. Concise review: mesenchymal stem cells: from
               roots to boost. Stem Cells. 2019;37:855–64.
           8.   Liu D, Cheng F, Pan S, Liu Z. Stem cells: a potential treatment option for kidney disease.
               Stem Cell Res. 2020;11:249-68.







































          16                                                                      Plenary
   26   27   28   29   30   31   32   33   34   35   36